Wada Y - Search Results

1

Randomised, multicentre prospective trial of transarterial chemoembolisation (TACE) plus sorafenib as compared with TACE alone in patients with hepatocellular carcinoma: TACTICS trial.

Kudo M, Ueshima K, Ikeda M, Torimura T, Tanabe N, Aikata H, Izumi N, Yamasaki T, Nojiri S, Hino K, Tsumura H, Kuzuya T, Isoda N, Yasui K, Aino H, Ido A, Kawabe N, Nakao K, Wada Y, Yokosuka O, Yoshimura K, Okusaka T, Furuse J, Kokudo N, Okita K, Johnson PJ, Arai Y; TACTICS study group. Kudo M, et al. Among authors: wada y. Gut. 2020 Aug;69(8):1492-1501. doi: 10.1136/gutjnl-2019-318934. Epub 2019 Dec 4. Gut. 2020. PMID: 31801872 Free PMC article. Clinical Trial.

2

Evaluation of intraoperative microwave coagulo-necrotic therapy (MCN) for hepatocellular carcinoma: a single center experience of 719 consecutive cases.

Takami Y, Ryu T, Wada Y, Saitsu H. Takami Y, et al. Among authors: wada y. J Hepatobiliary Pancreat Sci. 2013 Mar;20(3):332-41. doi: 10.1007/s00534-012-0527-5. J Hepatobiliary Pancreat Sci. 2013. PMID: 22710886 Free PMC article.

3

The Efficacy of Continued Sorafenib Treatment after Radiologic Confirmation of Progressive Disease in Patients with Advanced Hepatocellular Carcinoma.

Wada Y, Takami Y, Tateishi M, Ryu T, Mikagi K, Saitsu H. Wada Y, et al. PLoS One. 2016 Jan 8;11(1):e0146456. doi: 10.1371/journal.pone.0146456. eCollection 2016. PLoS One. 2016. PMID: 26745625 Free PMC article.

4

A randomised controlled trial of meloxicam, a Cox-2 inhibitor, to prevent hepatocellular carcinoma recurrence after initial curative treatment.

Takami Y, Eguchi S, Tateishi M, Ryu T, Mikagi K, Wada Y, Saitsu H. Takami Y, et al. Among authors: wada y. Hepatol Int. 2016 Sep;10(5):799-806. doi: 10.1007/s12072-016-9704-y. Epub 2016 Feb 4. Hepatol Int. 2016. PMID: 26846471 Free PMC article. Clinical Trial.

5

Ramucirumab as second-line treatment in patients with advanced hepatocellular carcinoma: Japanese subgroup analysis of the REACH trial.

Kudo M, Hatano E, Ohkawa S, Fujii H, Masumoto A, Furuse J, Wada Y, Ishii H, Obi S, Kaneko S, Kawazoe S, Yokosuka O, Ikeda M, Ukai K, Morita S, Tsuji A, Kudo T, Shimada M, Osaki Y, Tateishi R, Sugiyama G, Abada PB, Yang L, Okusaka T, Zhu AX. Kudo M, et al. Among authors: wada y. J Gastroenterol. 2017 Apr;52(4):494-503. doi: 10.1007/s00535-016-1247-4. Epub 2016 Aug 22. J Gastroenterol. 2017. PMID: 27549242 Clinical Trial.

6

Ramucirumab as Second-Line Treatment in Patients With Advanced Hepatocellular Carcinoma: Analysis of REACH Trial Results by Child-Pugh Score.

Zhu AX, Baron AD, Malfertheiner P, Kudo M, Kawazoe S, Pezet D, Weissinger F, Brandi G, Barone CA, Okusaka T, Wada Y, Park JO, Ryoo BY, Cho JY, Chung HC, Li CP, Yen CJ, Lee KD, Chang SC, Yang L, Abada PB, Chau I. Zhu AX, et al. Among authors: wada y. JAMA Oncol. 2017 Feb 1;3(2):235-243. doi: 10.1001/jamaoncol.2016.4115. JAMA Oncol. 2017. PMID: 27657674

7

The Safety and Efficacy of Combination Therapy of Sorafenib and Radiotherapy for Advanced Hepatocellular Carcinoma: A Retrospective Study.

Wada Y, Takami Y, Matsushima H, Tateishi M, Ryu T, Yoshitomi M, Matsumura T, Saitsu H. Wada Y, et al. Intern Med. 2018 May 15;57(10):1345-1353. doi: 10.2169/internalmedicine.9826-17. Epub 2017 Dec 27. Intern Med. 2018. PMID: 29279513 Free PMC article.

8

Effect of achieving sustained virological response before hepatitis C virus-related hepatocellular carcinoma occurrence on survival and recurrence after curative surgical microwave ablation.

Ryu T, Takami Y, Wada Y, Tateishi M, Matsushima H, Yoshitomi M, Mikagi K, Saitsu H. Ryu T, et al. Among authors: wada y. Hepatol Int. 2018 Mar;12(2):149-157. doi: 10.1007/s12072-018-9851-4. Epub 2018 Feb 27. Hepatol Int. 2018. PMID: 29488056

9

Prognosis of Hepatocellular Carcinoma Patients Who Achieved Long-Term Recurrence-Free Survival After Curative Therapy: Impact of the ALBI Grade.

Matsushima H, Takami Y, Ryu T, Yoshitomi M, Tateishi M, Wada Y, Saitsu H. Matsushima H, et al. Among authors: wada y. J Gastrointest Surg. 2018 Jul;22(7):1230-1238. doi: 10.1007/s11605-018-3745-6. Epub 2018 May 7. J Gastrointest Surg. 2018. PMID: 29736665

10

Actual 10-Year Survival After Surgical Microwave Ablation for Hepatocellular Carcinoma: A Single-Center Experience in Japan.

Ryu T, Takami Y, Wada Y, Hara T, Sasaki S, Saitsu H. Ryu T, et al. Among authors: wada y. Ann Surg Oncol. 2019 Nov;26(12):4126-4133. doi: 10.1245/s10434-019-07646-8. Epub 2019 Jul 29. Ann Surg Oncol. 2019. PMID: 31359277 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

3,658 results

Search Page